Stocks › PRVA
Privia Health PRVA
US equityMarket cap rank #2385
$25.05 +$0.36 (+1.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.05 0.00%
Open$24.59
Prev close$24.69
Day range$24.52 – $25.40
Volume1.93M
Market cap$3.20B
P/E (TTM)96.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$656.96M+13.2% YoY
Operating profit$20.54M+42.6% YoY
Net profit$14.59M+48.8% YoY
Diluted EPS$0.10+100.0% YoY
Free cash flow$28.94M-44.3% YoY
Operating cash flow$28.94M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin9.9%
Operating margin2.1%
Net margin1.4%
Return on equity4.6%
Return on assets2.4%
Return on invested capital4.5%
Current ratio1.63
Liabilities / assets44.2%
Cash & investments$446.28M
Total debt$6.15M
Net cash (debt)$440.13M
Free cash flow / sales4.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $656.96M | $632.63M | $603.85M | $2.12B | $541.17M |
| Total Operating Revenue | $656.96M | $632.63M | $603.85M | $2.12B | $541.17M |
| Cost of Revenue | $588.52M | $569.84M | $543.54M | $1.91B | $491.52M |
| Gross Profit | $68.44M | $62.79M | $60.31M | $209.43M | $49.66M |
| Operating Expense | $47.90M | $51.02M | $52.89M | $175.20M | $38.38M |
| Selling and Admin Expenses | $44.39M | $47.66M | $49.61M | $165.29M | $35.72M |
| -Selling & Marketing Expense | $9.94M | $8.00M | $8.13M | $27.14M | $6.45M |
| -General & Admin Expense | $34.45M | $39.66M | $41.47M | $138.15M | $29.27M |
| Depreciation & Amortization & Depletion | $3.50M | $3.36M | $3.28M | $9.91M | $2.66M |
| -Depreciation & Amortization | $3.50M | $3.36M | $3.28M | $9.91M | $2.66M |
| Operating Profit | $20.54M | $11.77M | $7.42M | $34.24M | $11.28M |
| Net Non-Operating Interest Income (Expense) | $1.72M | $1.67M | $1.89M | $9.70M | $2.09M |
| Non-Operating Interest Income | $1.72M | $1.67M | $1.89M | – | – |
| Pretax Profit | $22.27M | $16.75M | $9.31M | $43.94M | $13.37M |
| Tax | $7.67M | $7.02M | $5.60M | $14.21M | $2.79M |
| Net Profit | $14.59M | $9.73M | $3.71M | $29.73M | $10.59M |
| Profit from Continuing Operations | $14.59M | $9.73M | $3.71M | $29.73M | $10.59M |
| Minority Interests | $1.11M | $686,000.00 | $646,000.00 | $6.81M | $1.43M |
| Net Income to Parent Company | $13.49M | $9.05M | $3.06M | $22.92M | $9.15M |
| Net Income to Common Stockholders | $13.49M | $9.05M | $3.06M | $22.92M | $9.15M |
| Basic EPS | $0.11 | $0.07 | $0.02 | $0.19 | $0.07 |
| Diluted EPS | $0.10 | $0.07 | $0.02 | $0.18 | $0.07 |
| Other Income (Expense) | – | $3.31M | – | – | – |
| Other Non-Operating Income (Expenses) | – | $3.31M | – | – | – |
| Total Other Finance Costs | – | – | – | -$9.70M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.56B | $1.49B | $1.42B | $1.37B | $1.37B |
| Total Current Assets | $1.10B | $1.03B | $966.02M | $911.00M | $911.00M |
| Cash and Cash Equivalents & Short-Term Investments | $446.28M | $412.20M | $419.52M | $479.69M | $479.69M |
| -Cash and Cash Equivalents | $446.28M | $412.20M | $419.52M | $479.69M | $479.69M |
| Receivables | $623.58M | $574.16M | $513.68M | $400.90M | $400.90M |
| -Accounts Receivable | $623.58M | $574.16M | $513.68M | $400.90M | $400.90M |
| Other Current Assets | $29.69M | $38.91M | $32.82M | $30.41M | $30.41M |
| Total Non-Current Assets | $464.16M | $463.32M | $451.87M | $458.38M | $458.38M |
| Net PPE | $8.55M | $8.31M | $8.69M | $9.30M | $9.30M |
| -Gross PPE | $8.55M | $8.31M | $8.69M | $16.84M | $16.84M |
| Goodwill and Other Intangible Assets | $431.08M | $434.44M | $422.63M | $425.76M | $425.76M |
| -Goodwill | $215.79M | $215.79M | $209.84M | $209.84M | $209.84M |
| -Other Intangible Assets | $215.29M | $218.65M | $212.78M | $215.92M | $215.92M |
| Non-Current Deferred Assets | $0.00 | $0.00 | $0.00 | $2.27M | $2.27M |
| Other Non-Current Assets | $24.53M | $20.56M | $20.55M | $21.04M | $21.04M |
| Total Liabilities | $690.80M | $650.51M | $611.99M | $578.44M | $578.44M |
| Total Current Liabilities | $674.36M | $634.44M | $601.30M | $568.52M | $568.52M |
| Payables | $8.20M | $8.49M | $10.65M | $7.97M | $7.97M |
| -Accounts Payable | $8.20M | $8.49M | $10.65M | $7.97M | $7.97M |
| Current Accrued Expenses | $63.39M | $61.23M | $55.61M | $55.28M | $55.28M |
| Short-Term Debt and Capital Lease Obligation | $2.11M | $2.07M | $2.11M | $2.20M | $2.20M |
| -Current Capital Lease Obligation | $2.11M | $2.07M | $2.11M | $2.20M | $2.20M |
| Other Current Liabilities | $572.50M | $541.37M | $518.63M | $469.52M | $469.52M |
| Total Non-Current Liabilities | $16.45M | $16.06M | $10.69M | $9.92M | $9.92M |
| Long Term Debt and Capital Lease Obligation | $6.15M | $6.67M | $6.91M | $7.33M | $7.33M |
| -Long Term Capital Lease Obligation | $6.15M | $6.67M | $6.91M | $7.33M | $7.33M |
| Non-Current Deferred Liabilities | $3.94M | $3.74M | $254,000.00 | – | – |
| Other Non-Current Liabilities | $6.35M | $5.66M | $3.53M | $2.58M | $2.58M |
| Total Equity | $872.91M | $838.07M | $805.90M | $790.94M | $790.94M |
| Stockholders' Equity | $815.72M | $782.33M | $753.06M | $737.22M | $737.22M |
| Capital Stock | $1.28M | $1.26M | $1.26M | $1.24M | $1.24M |
| -Common Stock | $1.28M | $1.26M | $1.26M | $1.24M | $1.24M |
| Additional Paid-In Capital | $945.15M | $925.26M | $905.05M | $892.29M | $892.29M |
| Retained Earnings | -$130.71M | -$144.20M | -$153.25M | -$156.31M | -$156.31M |
| Minority Interests | $57.20M | $55.74M | $52.85M | $53.73M | $53.73M |
| -Accumulated Depreciation | – | – | – | -$7.54M | -$7.54M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $28.94M | $1.10M | -$49.47M | $163.40M | $127.50M |
| Net cash flow from continuing operations | $28.94M | $1.10M | -$49.47M | $163.40M | $127.50M |
| Net Income from Continuing Operations | $14.59M | $9.73M | $3.71M | $29.73M | $10.59M |
| Depreciation & Depletion & Amortization | $3.50M | $3.36M | $3.28M | $9.91M | $2.66M |
| Deferred Tax | $205,000.00 | $1.16M | $2.53M | $10.87M | $1.53M |
| Change in Working Capital | -$3.40M | -$32.54M | -$80.91M | $41.83M | $97.27M |
| -Change in Receivables | -$49.42M | -$59.60M | -$112.77M | -$36.67M | $139.88M |
| -Change in Prepaid Assets | $9.21M | -$6.08M | -$2.41M | -$1.60M | $1.44M |
| -Change in Payables and Accrued Expense | $8.74M | $10.46M | -$16.25M | $14.82M | $12.14M |
| -Change in Other Current Assets | -$3.28M | $494,000.00 | $978,000.00 | -$326,000.00 | -$2.67M |
| -Change in Other Current Liabilities | $31.35M | $22.20M | $49.55M | $65.60M | -$53.51M |
| Net cash flow from investing | -$1.07M | -$11.46M | -$26,000.00 | -$181.57M | -$91.31M |
| Net Cash Flow from Continuing Investing Activities | -$1.07M | -$11.46M | -$26,000.00 | -$181.57M | -$91.31M |
| Net Business Purchase and Sale | $0.00 | – | – | -$180.37M | -$91.31M |
| Net Other Investing Changes | -$1.07M | -$33,000.00 | -$26,000.00 | -$1.20M | $0.00 |
| Financing Cash Flow | $6.22M | $3.04M | -$10.67M | $6.70M | $2.15M |
| Net Cash Flow from Continuing Financing Activities | $6.22M | $3.04M | -$10.67M | $6.70M | $2.15M |
| Proceeds from Stock Option Exercised | $5.87M | $826,000.00 | $774,000.00 | $8.05M | $3.49M |
| Net Other Financing Charges | $347,000.00 | $2.21M | -$11.44M | -$1.35M | – |
| Ending Cash Balance | $446.28M | $412.20M | $419.52M | $479.69M | $479.69M |
| Net Change in Cash | $34.08M | -$7.32M | -$60.16M | -$11.46M | $38.33M |
| Beginning Cash Balance | $412.20M | $419.52M | $479.69M | $491.15M | $441.35M |
| Free Cash Flow | $28.94M | $1.10M | -$49.47M | $163.40M | $127.50M |
No comments yet — be the first to weigh in on PRVA.
Sign in to join the discussion.